Literature DB >> 19926305

The association between alcohol consumption and morbidity and mortality in patients undergoing coronary artery bypass surgery.

Ankit Maheshwari1, Jarrod E Dalton, Jean-Pierre Yared, Edward J Mascha, Andrea Kurz, Daniel I Sessler.   

Abstract

OBJECTIVE: Moderate alcohol consumption appears protective against cardiovascular events and mortality in community-based epidemiologic studies, but whether its consumption affects perioperative outcomes remains unknown. Therefore, the authors tested the hypothesis that alcohol consumption of 3 or more drinks per week improves postoperative outcomes in patients undergoing coronary artery bypass graft (CABG) surgery.
DESIGN: A propensity-matched retrospective cohort study.
SETTING: A major cardiovascular surgical institute, tertiary care teaching hospital. PARTICIPANTS: Data from 13,065 patients undergoing elective CABG surgery at the Cleveland Clinic were analyzed.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Propensity scores were used to match alcohol users with infrequent/nonusers. From the matched subset, the relationship between alcohol use and the composite outcome (any major cardiac, renal, respiratory, infectious, or neurologic morbidity and mortality) was determined univariably with the Pearson chi-square test and multivariably using stepwise logistic regression. Estimation of the relationship between such alcohol use and hospital length of stay was of secondary interest. Patients who reported consuming at least 3 drinks per week experienced similar odds of the composite outcome (adjusted odds ratio [95% confidence interval] of 1.13 [0.96-1.34], p = 0.14) to infrequent or nonusers. In a secondary analysis, the hospital length of stay was unrelated to alcohol use (adjusted hazard ratio [95% CI] of 1.03 [0.97-1.09], p = 0.28).
CONCLUSION: The present results showed that alcohol consumption was not associated with the risk for postoperative complications in patients undergoing CABG surgery. Alcohol abusers could not be separated in this study, and, based on previous literature, this result might not be applied to them. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19926305     DOI: 10.1053/j.jvca.2009.09.003

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Arthroplasty knee surgery and alcohol use: risk factor or benefit?

Authors:  Carlos J Lavernia; Jesus M Villa; Juan S Contreras
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

2.  Impact of alcohol use on 30-day complication and readmission rates after elective spinal fusion (≥2 levels) for adult spine deformity: a single institutional study of 1,010 patients.

Authors:  Aladine A Elsamadicy; Owoicho Adogwa; Victoria D Vuong; Amanda Sergesketter; Gireesh Reddy; Joseph Cheng; Carlos A Bagley; Isaac O Karikari
Journal:  J Spine Surg       Date:  2017-09

3.  Discharge β-Blocker Use and Race after Coronary Artery Bypass Grafting.

Authors:  Wesley T O'Neal; Jimmy T Efird; Stephen W Davies; Jason B O'Neal; William F Griffin; T Bruce Ferguson; W Randolph Chitwood; Alan P Kypson
Journal:  Front Public Health       Date:  2014-07-29

4.  Alcohol consumption and mortality in patients undergoing coronary artery bypass graft (CABG)-a register-based cohort study.

Authors:  Mads Phillip Kofoed Grabas; Steen Møller Hansen; Christian Torp-Pedersen; Henrik Bøggild; Line Rosenkilde Ullits; Ulrik Deding; Berit Jamie Nielsen; Per Føge Jensen; Charlotte Overgaard
Journal:  BMC Cardiovasc Disord       Date:  2016-11-11       Impact factor: 2.298

5.  Updating EuroSCORE by including emotional, behavioural, social and functional factors to the risk assessment of patients undergoing cardiac surgery: a study protocol.

Authors:  Pernille Fevejle Cromhout; Selina Kikkenborg Berg; Philip Moons; Sune Damgaard; Samer Nashef; Lau Caspar Thygesen
Journal:  BMJ Open       Date:  2019-07-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.